![\"Samsung](\"https:\/\/img.us.news.samsung.com\/us\/wp-content\/uploads\/2026\/07\/07170723\/HSOC-photo1-268x178.png\")
\n\t\t\t\t\t\tThe TAH-DA study began recruiting participants from across North America in early 2026, with a goal of enrolling 200 adults from each decade of life between the ages of 40 and 89. After enrolling in the study, participants receive Samsung\u2019s Galaxy Watch<\/a> to record for one year a suite of health metrics throughout the day and at night while they sleep, as well as Galaxy Tab<\/a> A9 that participants will use to self-assess and train their cognitive control abilities.<\/p>\n Galaxy Watch<\/a> measures a comprehensive set of health metrics, including heart rate, ECG (electrocardiogram), blood pressure, blood oxygen levels, and body composition (BIA). 1,2,3,4<\/sup> It also offers sleep and skin temperature tracking, 5 as well as daily activity tracking, such as step counts. This data will be used to develop unique insights and deployable algorithms to track and predict changes in brain health over time. Additionally, participants will engage in a series of surveys, digital cognitive assessments, and Neuroscape-developed digital interventions on a Samsung tablet.<\/p>\n “With this rich dataset, we will be able to determine which passive, biometric measures are associated with cognitive assessments, as well as test the effects of our evidence-based, digital interventions in boosting cognitive function in adults across their lifespans,” said Joaquin A. Anguera of Neuroscape. \u201cUnlike traditional neuroscience studies, which often use highly controlled, simplified stimuli and static laboratory environments, modern approaches look to study human cognition in real-world contexts and in real-time.\u201d<\/p>\n Mobile phones and wearables have become essential in daily life, capturing detailed information about users\u2019 habits and behaviors. Device data captures subtle routine changes with remarkably high sensitivity. Recognizing this potential, researchers at Samsung and UCSF hope to develop digital biomarker technology designed to support tracking changes in cognitive function through this partnership.<\/p>\n “We are thrilled to partner with Samsung on this research project, which combines its wearable technology and tablets with our software to study cognition in the real world,\u201d said Adam Gazzaley, executive director of Neuroscape. “This academic-industry partnership is driving the most technologically ambitious remote trial we\u2019ve ever attempted and will generate a unique perspective on human aging.\u201d<\/p>\n The remote study will use the Neuroscape-developed clinical trials platform, Nexus, which enables online deployment of all study-related activities, including enrollment, consent, diagnostic assessments, and digital interventions. The project will also include partnerships with Helpsquad (providing participants access to both an AI chatbot and a virtual assistant) and didit.me to assist with identification verification during the enrollment process.<\/p>\n “We are happy to have Neuroscape’s digital interventions combined with our technology to enhance the digital health ecosystem and create new approaches to well-being,” said Praveen Raja<\/a>, Vice President of Digital Health Samsung Research America. “Using biometric data from our Galaxy Watch<\/a>, we are excited to support the identification of behavioral and physiological predictors of cognitive decline, while looking toward digital interventions for improving cognition.”<\/p>\n “With this new study, we hope to raise the bar for remote trials,” said Theodore Zanto of Neuroscape. “Building off our past work, we continue to push the bounds of neurotechnology, looking to create neuroscience-based predictors of cognition across the adult lifespan, as well as new digital treatments.”<\/p>\n![\"Galaxy](\"https:\/\/img.us.news.samsung.com\/us\/wp-content\/uploads\/2022\/08\/25130354\/GW8_Newsroom-Module_launch.png\")
\n\t\t<\/a>\n\t<\/div>\nHow The Study Will Work<\/strong><\/h5>\n
\n